Owners, management and financials
CVR: 28111576
Secondary names: Originalis A/S
Previous names: ABACUS MEDICINE ApS
EUR 1,817,637,000
Revenue
Net result: EUR 7,779,000
Wagner Family Holding ApS (50-66,65%), CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB (33,33-49,99%)
CVR · view owners
Flemming Wagner
Board: Jens Albert Harsaae (chair) and 6 members
CVR · view management
Active
Founded 17 September 2004
CVR · view overview
173 employees
CVR · 2018
Owner registered: Wagner Family Holding ApS
CVR · 16/09/2019
View the full event history
ABACUS MEDICINE A/S is a Danish company of the type Aktieselskab based in København V, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ABACUS MEDICINE ApS. The management consists of Flemming Wagner. The board consists of Jens Albert Harsaae (chair), Alette Margaretha Verbeek, Anders Kunze Bønding and Flemming Wagner. The company is owned by Wagner Family Holding ApS and CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB. The company has 173 employees (2018). In 2025, the company reported revenue of EUR 1,817,637,000 and a net result of EUR 7,779,000 compared with EUR 17,621,000 the year before. Equity in the 2025 report amounted to EUR 98,523,000.
Source: annual report 2025, Danish Business Authority
ABACUS MEDICINE A/S demonstrates a strong upward trajectory in revenue and profitability, with 2025 revenue reaching €1.82 billion and a profit of €7.78 million, despite a decline in profit compared to the previous year. The company has shown consistent growth in revenue from €940.74 million in 2021 to €1.82 billion in 2025, indicating robust demand in the pharmaceutical wholesale sector. Its equity position has improved significantly, rising from €54.65 million in 2021 to €98.52 million in 2025, which reflects a solid financial foundation. However, the declining profit trend in recent years raises concerns about operational efficiency and margin management. Overall, ABACUS MEDICINE A/S is well-positioned in the industry, benefiting from increasing market demand but facing challenges in maintaining profitability.
AI-generated summary · Generated 20/08/2026
Selskabets formål er at drive parallelhandel med lægemidler, handel med medicin vedrørende ikke-registrerede lægemidler og handel med lægemidler i forbindelse med kliniske forsøg samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.8 mia. EUR | 7.8 mio. EUR | 494.7 mio. EUR | 98.5 mio. EUR | 1590 | |
| 202401/01/2024 – 31/12/2024 | 1.5 mia. EUR | 17.6 mio. EUR | 357.3 mio. EUR | 95.9 mio. EUR | - | |
| 202301/01/2023 – 31/12/2023 | 1.2 mia. EUR | 20 mio. EUR | 318.9 mio. EUR | 80.9 mio. EUR | - | |
| 202201/01/2022 – 31/12/2022 | 1 mia. EUR | 5.8 mio. EUR | 233 mio. EUR | 61 mio. EUR | - | |
| 202101/01/2021 – 31/12/2021 | 940.7 mio. EUR | 415 t. EUR | 215.6 mio. EUR | 54.6 mio. EUR | - | |
| 202001/01/2020 – 31/12/2020 | 663.5 mio. EUR | 433 t. EUR | 219.5 mio. EUR | 53 mio. EUR | - | |
| 201901/01/2019 – 31/12/2019 | 421.4 mio. EUR | 829 t. EUR | 127 mio. EUR | 51.6 mio. EUR | - | |
| 201801/01/2018 – 31/12/2018 | 332.3 mio. EUR | 5.4 mio. EUR | 97.2 mio. EUR | 14.4 mio. EUR | - | |
| 201701/01/2017 – 31/12/2017 | 253 t. | 4 t. | 57 t. | 10 t. | - | |
| 201601/01/2016 – 31/12/2016 | 1.3 mia. | 28.7 mio. | 250.9 mio. | 70.7 mio. | 67 | |
| 201501/01/2015 – 31/12/2015 | 835.5 mio. | 17.8 mio. | 179.8 mio. | 61.7 mio. | 46 | |
| 201401/01/2014 – 31/12/2014 | 625.2 mio. | 13.2 mio. | 93.1 mio. | 24.4 mio. | 39 | |
| 201301/01/2013 – 31/12/2013 | 489.5 mio. | 5.7 mio. | 74.1 mio. | 6.1 mio. | 40 |
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
65 public tenders won
Showing 10 of 65 contracts
See all won contracts on UdbudsScannerSources: TED (the EU tender database) and udbud.dk
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of ABACUS MEDICINE A/S is 28111576.
ABACUS MEDICINE A/S is owned by Wagner Family Holding ApS and CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB.
The management of ABACUS MEDICINE A/S consists of Flemming Wagner.
The board of ABACUS MEDICINE A/S consists of Jens Albert Harsaae, Alette Margaretha Verbeek and Anders Kunze Bønding, with Jens Albert Harsaae as chair.
In 2025, ABACUS MEDICINE A/S reported revenue of EUR 1,817,637,000.
ABACUS MEDICINE A/S had 173 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
ABACUS MEDICINE A/S has won the tender "Rammeaftale om køb af Livmarli (maralixibat)" issued by Amgros I/S worth 36,000,000 DKK.
Contact info changed: new phone: 70220212, new email: [email protected], new website: www.abacusmedicine.com (August 13, 2026).
Contact info changed: new phone: 70220212, new email: [email protected], new website: www.abacusmedicine.com (August 7, 2026).
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.164.a" issued by Amgros I/S worth 3,222,720 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.162.b" issued by Amgros I/S worth 733,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2027 1.1462.a" issued by Amgros I/S worth 121,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.501.a" issued by Amgros I/S worth 9,051,663 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2027 1.1189.a" issued by Amgros I/S worth 516,600,000 DKK.
ABACUS MEDICINE A/S has published its annual report for 2025. Revenue came to DKK 1,817,637,000, and the net result was DKK 7,779,000.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.987.a" issued by Amgros I/S worth 22,200,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.986.b" issued by Amgros I/S worth 125,640,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.170.b" issued by Amgros I/S worth 896,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.172.a" issued by Amgros I/S worth 55,100,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.974.a" issued by Amgros I/S worth 20,580,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.1305.a" issued by Amgros I/S worth 13,200,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.1306.b" issued by Amgros I/S worth 26,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.353.b" issued by Amgros I/S worth 2,321,995,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.450.b" issued by Amgros I/S worth 72,960,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.791.b" issued by Amgros I/S worth 95,885,483 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.708.b" issued by Amgros I/S worth 321,891,182 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.601.a" issued by Amgros I/S worth 331,750,548 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1201.a" issued by Amgros I/S worth 358,514,920 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.1302.b" issued by Amgros I/S worth 161,990,275 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.290.b" issued by Amgros I/S worth 88,050,546 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.611.b" issued by Amgros I/S worth 393,543,912 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1453.b" issued by Amgros I/S worth 155,400,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.617.b" issued by Amgros I/S worth 43,827,250 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.690.b" issued by Amgros I/S worth 217,081,515 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.210.a" issued by Amgros I/S worth 102,909,186 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.604.a" issued by Amgros I/S worth 501,367,776 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1507.a" issued by Amgros I/S worth 14,910,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.790.b" issued by Amgros I/S worth 66,631,361 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.703.b" issued by Amgros I/S worth 66,045,550 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 2.3.b" issued by Amgros I/S worth 382,769,201 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.704.b" issued by Amgros I/S worth 32,900,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.700.a" issued by Amgros I/S worth 245,033,539 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.702.b" issued by Amgros I/S worth 22,987,384 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.165.a" issued by Amgros I/S worth 1,566,600,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1053.b" issued by Amgros I/S worth 948,600,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2026 1.1042.b" issued by Amgros I/S worth 337,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.871.a" issued by Amgros I/S worth 1,473,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.986.b" issued by Amgros I/S worth 84,405,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.985.b" issued by Amgros I/S worth 522,750,000 DKK.
ABACUS MEDICINE A/S has published its annual report for 2024. Revenue came to DKK 1,486,964,000, and the net result was DKK 17,621,000.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.874.a" issued by Amgros I/S worth 10,400,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1314.a" issued by Amgros I/S worth 50,300,001 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.350.a" issued by Amgros I/S worth 20,097,600,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.551.a" issued by Amgros I/S worth 22,900,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1163.a" issued by Amgros I/S worth 1,644,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.709.a" issued by Amgros I/S worth 145,756,745 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1208.b" issued by Amgros I/S worth 7,330,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1201.a" issued by Amgros I/S worth 45,354,771 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1303.b" issued by Amgros I/S worth 14,267,938 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1305.a" issued by Amgros I/S worth 91,145,340 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1200.a" issued by Amgros I/S worth 101,036,383 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1203.a" issued by Amgros I/S worth 12,911,962 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1306.b" issued by Amgros I/S worth 18,679,198 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 2.3.b" issued by Amgros I/S worth 359,770,187 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.202.a" issued by Amgros I/S worth 33,091,130 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.203.b" issued by Amgros I/S worth 17,700,001 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.550.b" issued by Amgros I/S worth 652,620,000 DKK.
As of October 4, 2024, Alette Margaretha Verbeek has joined the board of directors of ABACUS MEDICINE A/S.
As of October 4, 2024, Sharon Evelyn Curran has joined the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has won the tender "Amgros 2024 1.1320.b" issued by Amgros I/S worth 3,160,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2024 1.480.b" issued by Amgros I/S worth 202,999,999 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2024 1.167.a" issued by Amgros I/S worth 291,550,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2024 1.1451.b" issued by Amgros I/S worth 95,200,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2024 1.481.b" issued by Amgros I/S worth 65,310,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2024 1.472.a" issued by Amgros I/S worth 20,675,200,000 DKK.
ABACUS MEDICINE A/S has published its annual report for 2023. Revenue came to DKK 1,210,354,000, and the net result was DKK 20,042,000.
As of March 15, 2024, Jens Albert Harsaae has joined the board of directors of ABACUS MEDICINE A/S.
As of March 15, 2024, Niels Smedegaard has left the board of directors of ABACUS MEDICINE A/S.
As of March 15, 2024, Michala Fischer-Hansen has left the board of directors of ABACUS MEDICINE A/S.
As of March 14, 2024, Jens Albert Harsaae has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2022. Revenue came to DKK 1,023,978,000, and the net result was DKK 5,819,000.
ABACUS MEDICINE A/S has published its annual report for 2021. Revenue came to DKK 940,740,000, and the net result was DKK 415,000.
As of September 29, 2021, Michala Fischer-Hansen has joined the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2020. Revenue came to DKK 663,501,000, and the net result was DKK 433,000.
ABACUS MEDICINE A/S has published its annual report for 2019. Revenue came to DKK 421,445,000, and the net result was DKK 829,000.
As of August 26, 2020, Troels Peter Troelsen has joined the board of directors of ABACUS MEDICINE A/S.
As of August 26, 2020, Niels Smedegaard has joined the board of directors of ABACUS MEDICINE A/S.
As of August 26, 2020, Ole Jensen has left the board of directors of ABACUS MEDICINE A/S.
As of August 25, 2020, Troels Peter Troelsen has left the board of directors of ABACUS MEDICINE A/S.
As of September 16, 2019, Jens Albert Harsaae has joined the board of directors of ABACUS MEDICINE A/S.
As of September 16, 2019, Mark Johnston has joined the board of directors of ABACUS MEDICINE A/S.
As of September 16, 2019, Anders Kunze Bønding has joined the board of directors of ABACUS MEDICINE A/S.
As of September 16, 2019, Wagner Family Holding ApS is registered as an owner of ABACUS MEDICINE A/S with an ownership share of 50%.
As of September 16, 2019, CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB is registered as an owner of ABACUS MEDICINE A/S with an ownership share of 33%.
As of September 15, 2019, Jens Albert Harsaae has left the board of directors of ABACUS MEDICINE A/S.
As of September 15, 2019, Anders Kunze Bønding has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2018. Revenue came to DKK 332,347,000, and the net result was DKK 5,359,000.
As of May 2, 2019, Anders Kunze Bønding has joined the board of directors of ABACUS MEDICINE A/S.
As of September 21, 2018, Jens Albert Harsaae has joined the board of directors of ABACUS MEDICINE A/S.
As of September 20, 2018, Jens Albert Harsaae has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2017. Revenue came to DKK 253,056, and the net result was DKK 4,328.
As of October 2, 2017, Bo Michael Palm has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2016. Revenue came to DKK 1,320,154,000, and the net result was DKK 28,655,000.
As of May 15, 2017, Jens Albert Harsaae has joined the board of directors of ABACUS MEDICINE A/S.
As of May 15, 2017, Bo Michael Palm has joined the board of directors of ABACUS MEDICINE A/S.
As of May 15, 2017, John Wagner has left the board of directors of ABACUS MEDICINE A/S.
As of May 15, 2017, Iwan Alstrup has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2015. Revenue came to DKK 835,482,000, and the net result was DKK 17,815,000.
ABACUS MEDICINE A/S has published its annual report for 2014. Revenue came to DKK 625,228,000, and the net result was DKK 13,224,000.
As of October 8, 2014, Ole Jensen has joined the board of directors of ABACUS MEDICINE A/S.
As of September 1, 2014, Iwan Alstrup has joined the board of directors of ABACUS MEDICINE A/S.
As of September 1, 2014, Lars Aaen has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2013. Revenue came to DKK 489,457,000, and the net result was DKK 5,653,000.
As of September 12, 2013, EY Godkendt Revisionspartnerselskab has been appointed auditor of ABACUS MEDICINE A/S.
As of August 29, 2013, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABACUS MEDICINE A/S.
As of August 28, 2013, Troels Peter Troelsen has joined the board of directors of ABACUS MEDICINE A/S.
As of August 28, 2013, Lars Christian Bruhn has left the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2012.
As of May 31, 2013, Lars Aaen has joined the board of directors of ABACUS MEDICINE A/S.
As of January 18, 2012, Lars Christian Bruhn has joined the board of directors of ABACUS MEDICINE A/S.
As of January 18, 2012, Per Villendrup Jenster has left the board of directors of ABACUS MEDICINE A/S.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ABACUS MEDICINE A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of ABACUS MEDICINE A/S.
On December 22, 2010, the company changed its name from ABACUS MEDICINE ApS to ABACUS MEDICINE A/S.
As of February 10, 2009, Flemming Wagner has joined the board of directors of ABACUS MEDICINE A/S.
As of February 10, 2009, Jytte Birgitte Wagner has left the board of directors of ABACUS MEDICINE A/S.
As of February 10, 2009, Flemming Wagner is registered as adm. dir. of ABACUS MEDICINE A/S.
As of February 10, 2009, John Wagner has stepped down as director of ABACUS MEDICINE A/S.
As of March 29, 2007, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of ABACUS MEDICINE A/S.
As of March 29, 2007, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of ABACUS MEDICINE A/S.
As of September 17, 2004, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of ABACUS MEDICINE A/S.
As of September 17, 2004, Per Villendrup Jenster has joined the board of directors of ABACUS MEDICINE A/S.
As of September 17, 2004, John Wagner has joined the board of directors of ABACUS MEDICINE A/S.
As of September 17, 2004, Jytte Birgitte Wagner has joined the board of directors of ABACUS MEDICINE A/S.
As of September 17, 2004, John Wagner is registered as director of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S was founded on September 17, 2004.
Companies in the same industry and area
CVR 36441127
CVR 41183144
CVR 35451307
CVR 37626619
CVR 36392398
